Ida N, Okura M, Tanaka S, Hosono N, et al. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair. Oncol Rep 2024;52:90.
PMID: 38785163